Global Macular Edema Therapeutics Market Research Report 2023

Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).

The global Macular Edema Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The market of macular edema is dominated by North America which is followed by Europe due tremendous number of population suffering from diabetics. Asia Pacific region have also shown faster rate of increases of macular edema therapeutics market. While Africa and Australia have low market of Macular edema. In Asia pacific region India, China and Brazil have shown emerging growth in the global market of macular edema therapeutics.

This report aims to provide a comprehensive presentation of the global market for Macular Edema Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macular Edema Therapeutics.

The Macular Edema Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Macular Edema Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Macular Edema Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Macular Edema Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Laser Treatment

1.2.3 Anti-VEGF Injection

1.2.4 Anti-Inflammatory Treatment

1.2.5 Vitrectomy

1.3 Market by Application

1.3.1 Global Macular Edema Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Cystoid Macular Edema (CME)

1.3.3 Diabetic Macular Edema(DME)

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Macular Edema Therapeutics Market Perspective (2018-2029)

2.2 Macular Edema Therapeutics Growth Trends by Region

2.2.1 Global Macular Edema Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Macular Edema Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Macular Edema Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Macular Edema Therapeutics Market Dynamics

2.3.1 Macular Edema Therapeutics Industry Trends

2.3.2 Macular Edema Therapeutics Market Drivers

2.3.3 Macular Edema Therapeutics Market Challenges

2.3.4 Macular Edema Therapeutics Market Restraints

3.1 Global Top Macular Edema Therapeutics Players by Revenue

3.1.1 Global Top Macular Edema Therapeutics Players by Revenue (2018-2023)

3.1.2 Global Macular Edema Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Macular Edema Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Macular Edema Therapeutics Revenue

3.4 Global Macular Edema Therapeutics Market Concentration Ratio

3.4.1 Global Macular Edema Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Macular Edema Therapeutics Revenue in 2022

3.5 Macular Edema Therapeutics Key Players Head office and Area Served

3.6 Key Players Macular Edema Therapeutics Product Solution and Service

3.7 Date of Enter into Macular Edema Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Macular Edema Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Macular Edema Therapeutics Forecasted Market Size by Type (2024-2029)

5.1 Global Macular Edema Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Macular Edema Therapeutics Forecasted Market Size by Application (2024-2029)

6.1 North America Macular Edema Therapeutics Market Size (2018-2029)

6.2 North America Macular Edema Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Macular Edema Therapeutics Market Size by Country (2018-2023)

6.4 North America Macular Edema Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Macular Edema Therapeutics Market Size (2018-2029)

7.2 Europe Macular Edema Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Macular Edema Therapeutics Market Size by Country (2018-2023)

7.4 Europe Macular Edema Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Macular Edema Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific Macular Edema Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Macular Edema Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific Macular Edema Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Macular Edema Therapeutics Market Size (2018-2029)

9.2 Latin America Macular Edema Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Macular Edema Therapeutics Market Size by Country (2018-2023)

9.4 Latin America Macular Edema Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Macular Edema Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa Macular Edema Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Macular Edema Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa Macular Edema Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Allergan

11.1.1 Allergan Company Detail

11.1.2 Allergan Business Overview

11.1.3 Allergan Macular Edema Therapeutics Introduction

11.1.4 Allergan Revenue in Macular Edema Therapeutics Business (2018-2023)

11.1.5 Allergan Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Macular Edema Therapeutics Introduction

11.2.4 Novartis Revenue in Macular Edema Therapeutics Business (2018-2023)

11.2.5 Novartis Recent Development

11.3 Roche

11.3.1 Roche Company Detail

11.3.2 Roche Business Overview

11.3.3 Roche Macular Edema Therapeutics Introduction

11.3.4 Roche Revenue in Macular Edema Therapeutics Business (2018-2023)

11.3.5 Roche Recent Development

11.4 Regeneron Pharmaceuticals

11.4.1 Regeneron Pharmaceuticals Company Detail

11.4.2 Regeneron Pharmaceuticals Business Overview

11.4.3 Regeneron Pharmaceuticals Macular Edema Therapeutics Introduction

11.4.4 Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2018-2023)

11.4.5 Regeneron Pharmaceuticals Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Detail

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Macular Edema Therapeutics Introduction

11.5.4 Pfizer Revenue in Macular Edema Therapeutics Business (2018-2023)

11.5.5 Pfizer Recent Development

11.6 Bayer

11.6.1 Bayer Company Detail

11.6.2 Bayer Business Overview

11.6.3 Bayer Macular Edema Therapeutics Introduction

11.6.4 Bayer Revenue in Macular Edema Therapeutics Business (2018-2023)

11.6.5 Bayer Recent Development

11.7 Boehringer Ingelheim

11.7.1 Boehringer Ingelheim Company Detail

11.7.2 Boehringer Ingelheim Business Overview

11.7.3 Boehringer Ingelheim Macular Edema Therapeutics Introduction

11.7.4 Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2018-2023)

11.7.5 Boehringer Ingelheim Recent Development

11.8 Bausch & Lomb

11.8.1 Bausch & Lomb Company Detail

11.8.2 Bausch & Lomb Business Overview

11.8.3 Bausch & Lomb Macular Edema Therapeutics Introduction

11.8.4 Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2018-2023)

11.8.5 Bausch & Lomb Recent Development

11.9 Aciont

11.9.1 Aciont Company Detail

11.9.2 Aciont Business Overview

11.9.3 Aciont Macular Edema Therapeutics Introduction

11.9.4 Aciont Revenue in Macular Edema Therapeutics Business (2018-2023)

11.9.5 Aciont Recent Development

11.10 ActiveSite Pharmaceuticals

11.10.1 ActiveSite Pharmaceuticals Company Detail

11.10.2 ActiveSite Pharmaceuticals Business Overview

11.10.3 ActiveSite Pharmaceuticals Macular Edema Therapeutics Introduction

11.10.4 ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2018-2023)

11.10.5 ActiveSite Pharmaceuticals Recent Development

11.11 Adverum Biotechnologies

11.11.1 Adverum Biotechnologies Company Detail

11.11.2 Adverum Biotechnologies Business Overview

11.11.3 Adverum Biotechnologies Macular Edema Therapeutics Introduction

11.11.4 Adverum Biotechnologies Revenue in Macular Edema Therapeutics Business (2018-2023)

11.11.5 Adverum Biotechnologies Recent Development

11.12 Aerpio Therapeutics

11.12.1 Aerpio Therapeutics Company Detail

11.12.2 Aerpio Therapeutics Business Overview

11.12.3 Aerpio Therapeutics Macular Edema Therapeutics Introduction

11.12.4 Aerpio Therapeutics Revenue in Macular Edema Therapeutics Business (2018-2023)

11.12.5 Aerpio Therapeutics Recent Development

11.13 Ampio Pharmaceuticals

11.13.1 Ampio Pharmaceuticals Company Detail

11.13.2 Ampio Pharmaceuticals Business Overview

11.13.3 Ampio Pharmaceuticals Macular Edema Therapeutics Introduction

11.13.4 Ampio Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2018-2023)

11.13.5 Ampio Pharmaceuticals Recent Development

11.14 Araim Pharmaceuticals

11.14.1 Araim Pharmaceuticals Company Detail

11.14.2 Araim Pharmaceuticals Business Overview

11.14.3 Araim Pharmaceuticals Macular Edema Therapeutics Introduction

11.14.4 Araim Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2018-2023)

11.14.5 Araim Pharmaceuticals Recent Development

11.15 Astellas Pharma

11.15.1 Astellas Pharma Company Detail

11.15.2 Astellas Pharma Business Overview

11.15.3 Astellas Pharma Macular Edema Therapeutics Introduction

11.15.4 Astellas Pharma Revenue in Macular Edema Therapeutics Business (2018-2023)

11.15.5 Astellas Pharma Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Macular Edema Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Laser Treatment

    Table 3. Key Players of Anti-VEGF Injection

    Table 4. Key Players of Anti-Inflammatory Treatment

    Table 5. Key Players of Vitrectomy

    Table 6. Global Macular Edema Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Macular Edema Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Macular Edema Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Macular Edema Therapeutics Market Share by Region (2018-2023)

    Table 10. Global Macular Edema Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Macular Edema Therapeutics Market Share by Region (2024-2029)

    Table 12. Macular Edema Therapeutics Market Trends

    Table 13. Macular Edema Therapeutics Market Drivers

    Table 14. Macular Edema Therapeutics Market Challenges

    Table 15. Macular Edema Therapeutics Market Restraints

    Table 16. Global Macular Edema Therapeutics Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Macular Edema Therapeutics Market Share by Players (2018-2023)

    Table 18. Global Top Macular Edema Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Edema Therapeutics as of 2022)

    Table 19. Ranking of Global Top Macular Edema Therapeutics Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Macular Edema Therapeutics Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Macular Edema Therapeutics Product Solution and Service

    Table 23. Date of Enter into Macular Edema Therapeutics Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Macular Edema Therapeutics Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Macular Edema Therapeutics Revenue Market Share by Type (2018-2023)

    Table 27. Global Macular Edema Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Macular Edema Therapeutics Revenue Market Share by Type (2024-2029)

    Table 29. Global Macular Edema Therapeutics Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Macular Edema Therapeutics Revenue Market Share by Application (2018-2023)

    Table 31. Global Macular Edema Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Macular Edema Therapeutics Revenue Market Share by Application (2024-2029)

    Table 33. North America Macular Edema Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Macular Edema Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Macular Edema Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Macular Edema Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Macular Edema Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Macular Edema Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Macular Edema Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Macular Edema Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Macular Edema Therapeutics Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Macular Edema Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Macular Edema Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Macular Edema Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Macular Edema Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Macular Edema Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Macular Edema Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Allergan Company Detail

    Table 49. Allergan Business Overview

    Table 50. Allergan Macular Edema Therapeutics Product

    Table 51. Allergan Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 52. Allergan Recent Development

    Table 53. Novartis Company Detail

    Table 54. Novartis Business Overview

    Table 55. Novartis Macular Edema Therapeutics Product

    Table 56. Novartis Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 57. Novartis Recent Development

    Table 58. Roche Company Detail

    Table 59. Roche Business Overview

    Table 60. Roche Macular Edema Therapeutics Product

    Table 61. Roche Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 62. Roche Recent Development

    Table 63. Regeneron Pharmaceuticals Company Detail

    Table 64. Regeneron Pharmaceuticals Business Overview

    Table 65. Regeneron Pharmaceuticals Macular Edema Therapeutics Product

    Table 66. Regeneron Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 67. Regeneron Pharmaceuticals Recent Development

    Table 68. Pfizer Company Detail

    Table 69. Pfizer Business Overview

    Table 70. Pfizer Macular Edema Therapeutics Product

    Table 71. Pfizer Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 72. Pfizer Recent Development

    Table 73. Bayer Company Detail

    Table 74. Bayer Business Overview

    Table 75. Bayer Macular Edema Therapeutics Product

    Table 76. Bayer Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 77. Bayer Recent Development

    Table 78. Boehringer Ingelheim Company Detail

    Table 79. Boehringer Ingelheim Business Overview

    Table 80. Boehringer Ingelheim Macular Edema Therapeutics Product

    Table 81. Boehringer Ingelheim Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 82. Boehringer Ingelheim Recent Development

    Table 83. Bausch & Lomb Company Detail

    Table 84. Bausch & Lomb Business Overview

    Table 85. Bausch & Lomb Macular Edema Therapeutics Product

    Table 86. Bausch & Lomb Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 87. Bausch & Lomb Recent Development

    Table 88. Aciont Company Detail

    Table 89. Aciont Business Overview

    Table 90. Aciont Macular Edema Therapeutics Product

    Table 91. Aciont Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 92. Aciont Recent Development

    Table 93. ActiveSite Pharmaceuticals Company Detail

    Table 94. ActiveSite Pharmaceuticals Business Overview

    Table 95. ActiveSite Pharmaceuticals Macular Edema Therapeutics Product

    Table 96. ActiveSite Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 97. ActiveSite Pharmaceuticals Recent Development

    Table 98. Adverum Biotechnologies Company Detail

    Table 99. Adverum Biotechnologies Business Overview

    Table 100. Adverum Biotechnologies Macular Edema Therapeutics Product

    Table 101. Adverum Biotechnologies Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 102. Adverum Biotechnologies Recent Development

    Table 103. Aerpio Therapeutics Company Detail

    Table 104. Aerpio Therapeutics Business Overview

    Table 105. Aerpio Therapeutics Macular Edema Therapeutics Product

    Table 106. Aerpio Therapeutics Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 107. Aerpio Therapeutics Recent Development

    Table 108. Ampio Pharmaceuticals Company Detail

    Table 109. Ampio Pharmaceuticals Business Overview

    Table 110. Ampio Pharmaceuticals Macular Edema Therapeutics Product

    Table 111. Ampio Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 112. Ampio Pharmaceuticals Recent Development

    Table 113. Araim Pharmaceuticals Company Detail

    Table 114. Araim Pharmaceuticals Business Overview

    Table 115. Araim Pharmaceuticals Macular Edema Therapeutics Product

    Table 116. Araim Pharmaceuticals Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 117. Araim Pharmaceuticals Recent Development

    Table 118. Astellas Pharma Company Detail

    Table 119. Astellas Pharma Business Overview

    Table 120. Astellas Pharma Macular Edema Therapeutics Product

    Table 121. Astellas Pharma Revenue in Macular Edema Therapeutics Business (2018-2023) & (US$ Million)

    Table 122. Astellas Pharma Recent Development

    Table 123. Research Programs/Design for This Report

    Table 124. Key Data Information from Secondary Sources

    Table 125. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Macular Edema Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Macular Edema Therapeutics Market Share by Type: 2022 VS 2029

    Figure 3. Laser Treatment Features

    Figure 4. Anti-VEGF Injection Features

    Figure 5. Anti-Inflammatory Treatment Features

    Figure 6. Vitrectomy Features

    Figure 7. Global Macular Edema Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Macular Edema Therapeutics Market Share by Application: 2022 VS 2029

    Figure 9. Cystoid Macular Edema (CME) Case Studies

    Figure 10. Diabetic Macular Edema(DME) Case Studies

    Figure 11. Macular Edema Therapeutics Report Years Considered

    Figure 12. Global Macular Edema Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Macular Edema Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Macular Edema Therapeutics Market Share by Region: 2022 VS 2029

    Figure 15. Global Macular Edema Therapeutics Market Share by Players in 2022

    Figure 16. Global Top Macular Edema Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Edema Therapeutics as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Macular Edema Therapeutics Revenue in 2022

    Figure 18. North America Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Macular Edema Therapeutics Market Share by Country (2018-2029)

    Figure 20. United States Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Macular Edema Therapeutics Market Share by Country (2018-2029)

    Figure 24. Germany Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Macular Edema Therapeutics Market Share by Region (2018-2029)

    Figure 32. China Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Macular Edema Therapeutics Market Share by Country (2018-2029)

    Figure 40. Mexico Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Macular Edema Therapeutics Market Share by Country (2018-2029)

    Figure 44. Turkey Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Macular Edema Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Allergan Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 47. Novartis Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 48. Roche Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 49. Regeneron Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 50. Pfizer Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 51. Bayer Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 52. Boehringer Ingelheim Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 53. Bausch & Lomb Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 54. Aciont Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 55. ActiveSite Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 56. Adverum Biotechnologies Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 57. Aerpio Therapeutics Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 58. Ampio Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 59. Araim Pharmaceuticals Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 60. Astellas Pharma Revenue Growth Rate in Macular Edema Therapeutics Business (2018-2023)

    Figure 61. Bottom-up and Top-down Approaches for This Report

    Figure 62. Data Triangulation

    Figure 63. Key Executives Interviewed